A trial carried out entirely in Catalonia has shown that therapy with dolutegravir plus lamivudine has an efficacy similar to that of triple therapy. It does not cause resistance or have any side effe...
Read moreAn interview with Dr Albert Lladó, neurologist at the Alzheimer's and other Cognitive Disorders Unit. Dr Lladó treats dementias, including Alzheimer's, which is the most common. Here we will talk ab...
Read moreThe benchmark meeting in the field of immunotherapy cancer treatment was held once again, on April 9, in a hybrid format. This year, the presentations focused on the research and development of thi...
Read moreAgnès Arbat and Ignasi Canals lead Oxolife, a startup that is developing OXO-001, a drug with the potential to treat female infertility as it increases the chances of embryo implantation a 65%. Arba...
Read moreNew diagnostic test for MSI in solid tumors can inform physicians on immuno-oncology therapies, and can guide treatment decisions for patients with Lynch-associated cancers
Read moreThe review of the duration and depth of sleep or difficulty falling asleep allows us to offer comprehensive and personalized treatment to patients
Read moreResearchers from Cima and the Clínica Universidad de Navarra show that high IL-8 levels are linked to worse patient response to the treatment
Read moreTo ring in this year’s colorectal cancer awareness month this coming March, we have organized a special workshop open to the public taking place on Thursday 27 February, from 18:00h-20:00h, C/Rossel...
Read more3P Biopharmaceuticals, a leading Contract Development and Manufacturing Organization (CDMO) specialized in process development and cGMP manufacturing of biologics, has been chosen by In3Bio, the UK ba...
Read moreFrom 23 to 25 September, experts from around the world discuss at the international Congress CNIO-“la Caixa” Frontiers Meeting how the analysis of the currently available vast amounts of data on e...
Read moreA collaborative experimental study, published in Nature and led by researchers at the University of Navarra, suggests TNF blockade may dissociate efficacy and toxicity in the use of combined immunothe...
Read moreToday, marking Rare Disease Day, the European Commission is launching a new online knowledge-sharing platform to support better diagnosis and treatment for more than 30 million Europeans living with a...
Read more